Univ of Pittsburgh

Pittsburgh, Pennsylvania 15261

1 studies enrolling now · 22 studies all time

What they study most

Cognitive Disorders, Diabetes Mellitus, HIV Infection, HIV Infections, HIV Seronegativity, Hypercholesterolemia, Hyperinsulinemia, Hypertriglyceridemia, Lipodystrophy, Menopause, Papilloma, Pregnancy

Studies at this site

• Menopausal HT for Women Living With HIV (HoT) — Recruiting now
• Consent for Use of Stored Patient Specimens for Future Testing — Running, not enrolling
• A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease — Completed
• Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids — Completed
• The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS — Completed
• Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment — Withdrawn before enrolling
• Long-Term Data Collection From Participants in Adult AIDS Clinical Trials — Completed
• The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women — Completed
• Effects of Changing HIV Therapy at Lower Versus Higher Viral Loads — Completed
• Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities — Completed
• Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients — Completed
• Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance — Completed
• Changing to Nonprotease Inhibitor Treatment to Improve Side Effects — Completed
• Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection — Completed
• Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor — Completed
• A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors — Completed
• A Comparison of Two Tests for Anti-HIV Drug Resistance — Completed
• HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs — Completed
• Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women — Completed
• The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs — Completed
• A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults — Completed
• T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs — Completed